Furthermore, ANA-12 (TrkB antagonist) blocked the beneficial effects of (R)-ketamine in PCP model [46], suggesting a role of TrkB in the beneficial effects of (R)-ketamine. The gene discussed is NTRK2; the disease is pneumocystosis.